Atlas Trials

Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer

Clinical trial NCT06609759 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06609759
Sponsor
Qilu Hospital of Shandong University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Stage II-III Gastric Cancer
Start date
2024-01-01
Primary completion
2028-01-01
Enrollment
197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.